Therapeutic angiogenesis in cardiovascular disease

Area of Science:

• Cardiovascular Medicine
• Regenerative Medicine
• Vascular Biology

Background:

• Atherosclerotic arterial disease is a primary cause of significant morbidity and mortality, including coronary artery disease, peripheral vascular disease, and stroke.
• Standard treatments like angioplasty and bypass surgery are not suitable for all patients.
• There is a growing need for alternative therapeutic strategies to manage advanced atherosclerotic conditions.

Purpose of the Study:

• To review the therapeutic potential of angiogenesis in treating atherosclerotic arterial disease.
• To explore various approaches for augmenting physiological neovascularization in cardiovascular disease.
• To provide an overview of gene therapy, protein therapy, and cellular therapy for atherosclerotic arterial disease.

Main Methods:

• Literature review of existing research on therapeutic angiogenesis.
• Analysis of different pathways for inducing neovascularization.
• Synthesis of information on gene, protein, and cellular therapy applications.

Main Results:

• Therapeutic angiogenesis presents a promising avenue for patients unresponsive to conventional treatments.
• Gene therapy, protein therapy, and cellular therapy are key modalities for stimulating new blood vessel formation.
• These approaches aim to restore blood flow and improve tissue perfusion in diseased arteries.

Conclusions:

• Augmenting physiological neovascularization through therapeutic angiogenesis is a viable strategy for atherosclerotic arterial disease.
• Gene, protein, and cellular therapies offer distinct mechanisms to achieve therapeutic angiogenesis.
• Further research and clinical application of these therapies hold significant potential for improving patient outcomes.